New York, New York
United States
18
2021-07-08
The entities that hold a legal rights for patent applications filed by inventor Perez-Soler Roman:
Roman Perez-Soler from New York, US has applied for patents for these inventions. The list has both pending applications and granted patents:
RICTOR-TARGETED THERAPY IN THE MANAGEMENT OF BRAIN METASTASES
#2 | 2016-06-16METHODS OF TREATING CANCER WITH HIGH POTENCY LIPID-BASED PLATINUM COMPOUND FORMULATIONS ADMINISTERED INTRAPERITONEALLY
#3 | 2013-08-29VITAMIN K FOR PREVENTION AND TREATMENT OF SKIN RASH SECONDARY TO ANTI-EGFR THERAPY
#4 | 2010-12-23Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
#5 | 2010-03-04Methods for treating bronchial premalignancy and lung cancer
#6 | 2009-09-24VITAMIN K FOR PREVENTION AND TREATMENT OF SKIN RASH SECONDARY TO ANTI-EGFR THERAPY
#7 | 2009-08-20Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
#8 | 2009-05-21Methods of Treating Cancer with High Potency Lipid-Based Platinum Compound Formulations Administered Intravenously
#9 | 2009-05-21Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
#10 | 2007-08-16Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
#11 | 2007-08-16Methods of treating cancer with lipid-based platinum compound forumulations administered intravenously
#12 | 2007-08-16Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
#13 | 2007-02-15Anthracycline antibiotics and methods of treating cancer using the same
#14 | 2007-01-02Gene therapy of tumors using non-viral delivery system
#15 | 2006-11-02Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
#16 | 2006-07-27Gene therapy of tumors using non-viral delivery system
#17 | 2006-02-16Treatment of lung diseases and pre-lung disease conditions
#18 | 2005-01-06Methods and compositions for the manufacture of C-3′ and C-4′ anthracycline antibiotics
416632 ⎘